- Report
- January 2025
- 180 Pages
Global
From €5240EUR$5,950USD£4,606GBP
- Report
- May 2025
- 137 Pages
Global
From €2245EUR$2,549USD£1,974GBP
€2641EUR$2,999USD£2,322GBP
- Report
- October 2025
- 120 Pages
Global
From €5240EUR$5,950USD£4,606GBP
- Report
- May 2025
- 130 Pages
Global
From €5240EUR$5,950USD£4,606GBP
- Report
- November 2025
- 181 Pages
Global
From €3122EUR$3,545USD£2,745GBP
€3469EUR$3,939USD£3,050GBP
- Report
- December 2025
- 382 Pages
Global
From €5152EUR$5,850USD£4,529GBP
- Report
- October 2025
- 183 Pages
Global
From €3122EUR$3,545USD£2,745GBP
€3469EUR$3,939USD£3,050GBP
- Report
- October 2025
- 250 Pages
Global
From €3955EUR$4,490USD£3,476GBP
- Report
- April 2025
- 200 Pages
Global
From €3955EUR$4,490USD£3,476GBP
- Report
- February 2025
- 200 Pages
Global
From €3955EUR$4,490USD£3,476GBP
- Report
- January 2025
- 175 Pages
Global
From €3955EUR$4,490USD£3,476GBP
- Report
- July 2025
- 350 Pages
Global
From €4359EUR$4,949USD£3,831GBP
- Report
- October 2025
- 150 Pages
Global
From €3391EUR$3,850USD£2,981GBP
- Report
- October 2025
- 140 Pages
Global
From €3631EUR$4,123USD£3,192GBP
€4272EUR$4,850USD£3,755GBP
- Report
- December 2024
- 313 Pages
Global
From €4360EUR$4,950USD£3,832GBP
- Report
- February 2024
- 226 Pages
Global
From €3655EUR$4,150USD£3,213GBP
- Report
- June 2023
- 186 Pages
Global
From €4096EUR$4,650USD£3,600GBP
- Report
- March 2022
- 273 Pages
Global
From €2312EUR$2,625USD£2,032GBP
€4624EUR$5,250USD£4,065GBP
- Report
- October 2024
- 90 Pages
Asia Pacific
From €4360EUR$4,950USD£3,832GBP
- Report
- September 2023
- 190 Pages
Global
From €2193EUR$2,490USD£1,928GBP

Cervical cancer is a type of cancer that affects the cells of the cervix, the lower part of the uterus that connects to the vagina. It is the fourth most common cancer in women worldwide, and is caused by the human papillomavirus (HPV). Treatment for cervical cancer typically involves surgery, radiation therapy, chemotherapy, and targeted therapy.
The cervical cancer market is a subset of the larger oncology market, which is composed of drugs, diagnostics, and services used to treat cancer. The cervical cancer market is expected to grow due to the increasing prevalence of HPV, the development of new treatments, and the increasing availability of healthcare services.
Some companies in the cervical cancer market include Merck, Bristol-Myers Squibb, AstraZeneca, Roche, and Novartis. Show Less Read more